Introduction/Overview
Natural products, as an important source of drug discovery, play an irreplaceable role in the long history of human struggle against diseases. Among the many biologically active natural product families, the Maca plant originates from the South American plateau（Lepidium meyenii The Macamides compounds of Walp. have received high attention from the international natural product chemistry and pharmacology community in recent years due to their unique chemical structure and significant pharmacological activities such as neuroprotection, anti fatigue, and improvement of reproductive function. Macamide is a type of structurally unique N-benzyl long-chain fatty acid amide, characterized by a benzylamine group connected to fatty acids of different chain lengths and saturation levels through an amide bond. These compounds are considered to be the key material basis for maca to exert its various physiological activities.
In the complex family of macaramides, there are a series of structurally similar compounds and possible synthesis or degradation by-products, among which "macaramide impurity 9" (N - (3-methoxybenzyl) oleamide) is a compound worthy of further exploration. From a chemical structure perspective, this compound is formed by the amide condensation of oleic acid and 3-methoxybenzylamine. Compared with classical macaramides such as N-benzylhexadecanamide, N-benzyl-9Z-octadecanoamide, etc., its significant difference lies in the presence of a methoxy (- OCH ∝) substituent at the 3rd position (meta position) of the benzyl ring, rather than the classical unsubstituted benzyl group. This structural modification may have a profound impact on its physicochemical properties, biological activity, and metabolic behavior.
Although the compound is often classified as an "impurity" or "byproduct", in the context of natural product chemistry, the so-called "impurity" may often have unique biological activity and even be a potential precursor or metabolite of the active ingredient in some cases. At present, there are relatively limited systematic research reports on N - (3-methoxybenzyl) oleamide, and its clear endogenous presence, biosynthetic pathway, pharmacological activity spectrum, and mechanism of action in plants are not yet fully understood. However, given the extensive biological activity of the entire family of macacamide and the important role of methoxy substitution in regulating lipid solubility, metabolic stability, and target affinity in medicinal chemistry, a systematic review and prospective analysis of macacamide impurity 9 not only helps to improve the understanding of the Structure Activity Relationship (SAR) of macacamide compounds, but may also provide clues for the discovery of new lead compounds.
This article aims to provide a comprehensive and in-depth review of the chemical structure, physicochemical properties, plant origin, extraction methods, pharmacological activity, mechanism of action, drug properties, and clinical application prospects of N - (3-methoxybenzyl) oleamide, based on existing literature, in order to provide reference and inspiration for future research in this field.
Chemical structure and physicochemical properties
Chemical structure analysis
N-(3-Methoxybenzyl)oleamide， The system is named N - (3-methoxybenzyl) -9Z-octadecanenamide, and its chemical structure consists of three core components: a long-chain unsaturated fatty acid (oleic acid), an amide bond, and a substituted benzyl group (3-methoxybenzyl).
- Fatty acid portion Oleic acid (C18:1, Δ 9) is a monounsaturated Omega-9 fatty acid widely present in nature. Its carbon chain length is 18 carbon atoms, and there is a cis (Z) double bond between the 9th and 10th carbon atoms (counted from the carboxyl end). The presence of this double bond endows the molecule with a certain degree of flexibility and fluidity, and affects its interaction with biofilms.
- amide bond The carboxyl group of oleic acid undergoes dehydration condensation with the amino group of 3-methoxybenzylamine to form a stable amide bond (- CONH -). The amide bond is a key functional group that connects the fatty acid chain with the aromatic ring. It not only determines the basic skeleton of the molecule, but also participates in the interaction with biological targets through the donor/acceptor ability of hydrogen bonding.
- Aromatic ring part The 3-methoxybenzyl moiety is the key distinguishing feature of this compound from classical macamide (N-benzylamide). The 3rd position (meta position) of the benzyl ring is replaced by a methoxy group (- OCH ∝). Methoxy is an electron donating group that affects the electron cloud density of the benzene ring through induction and conjugation effects. This substitution mode may alter the polarity, hydrophobicity, and non covalent interaction abilities such as π - π stacking of molecules, thereby affecting their binding to specific proteins or receptors.
Prediction of physical and chemical properties
Based on its chemical structure, the physicochemical properties of N - (3-methoxybenzyl) oleamide can be reasonably predicted:
- Molecular formula and molecular weight C ₂₆ H ₄∝ NO ₂, with a molecular weight of approximately 401.63 g/mol.
- solubility Due to its long alkyl chain (hydrophobic tail), polar amide bond, and aromatic ring (hydrophilic head), this molecule exhibits typical amphiphilicity. It is extremely insoluble in water, but easily soluble in organic solvents such as methanol, ethanol, dimethyl sulfoxide (DMSO), chloroform, ethyl acetate, etc. Its lipophilicity (LogP) is expected to be high, typically between 6-8, indicating strong membrane permeability and ease of crossing cell membranes and the blood-brain barrier.
- Stability The amide bond is relatively stable under conventional conditions, but can undergo hydrolysis under strong acid or strong base conditions. The double bond (cis) of oleic acid may undergo isomerization (conversion to trans) or oxidative degradation under light, high temperature, or the presence of oxidants. Methoxy groups may undergo ether bond cleavage under strong acid conditions.
- spectral characteristics Characteristic absorption peaks of amide I band (~1650 cm ⁻¹) and amide II band (~1550 cm ⁻¹) can be observed in infrared spectroscopy (IR), as well as C-H stretching vibration (~330 cm ⁻¹) and C=C stretching vibration (~1600, 1500 cm ⁻¹) of the benzene ring. In the nuclear magnetic resonance hydrogen spectrum (¹ H NMR), the terminal methyl (δ 0.9 ppm), methylene (δ 1.2-1.4 ppm), olefin proton (δ 5.3-5.4 ppm), benzyl proton (δ 7.0-7.3 ppm), and methoxy proton (δ 3.8 ppm) of the oleic acid chain can all provide clear structural information. In mass spectrometry (MS), the molecular ion peak [M+H] ⁺ should be m/z 402.3 and can be confirmed by characteristic fragment ions such as benzyl cations or fatty acid chain fragments.
Plant sources and extraction methods
Plant-based
The naming of N - (3-methoxybenzyl) oleamide impurity 9 implies its association with macamide（Lepidium meyenii）Closely related. However, it should be noted that the content of this compound in natural maca roots is usually extremely low and may not even be the main endogenous secondary metabolite.
- Macamide spectrum in maca Classic macaramides, such as N-benzylhexadecanamide, N-benzyl-9Z-octadecadienamide, N-benzyl-9Z, 12Z octadecadienamide, etc., are abundant and widely studied active ingredients in macarons. These compounds are characterized by unsubstituted benzyl groups.
- The presence of methoxy substituted macacamide Some studies have reported that in maca extracts, in addition to the main unsubstituted benzylamide, trace amounts of analogues with hydroxyl (- OH) or methoxy (- OCH ∝) substituents on the benzyl ring were also detected. For example, N - (3-methoxybenzyl) hexadecanamide, N - (3-methoxybenzyl) -9Z-octadecanoamide, etc. These methoxy substituted compounds are considered secondary products or by-products in the biosynthesis pathway of macamide. Its sources may include:
- Biosynthetic pathway In plants, the synthesis of benzylamine may involve the phenylalanine pathway. 3-methoxybenzylamine may be derived from the decarboxylation of 3-methoxyphenylalanine (a non protein amino acid), or through modification steps such as hydroxylation and methylation of benzylamine.
- Chemical synthesis by-products During the extraction, separation, or storage process of maca, certain chemical reactions (such as methylation) may lead to the transformation of unsubstituted benzylamides into methoxy substituted forms.
- Impurities in analysis and identification In high-performance liquid chromatography (HPLC) or mass spectrometry (MS) analysis, due to their similar structures, methoxy substituted amides are often detected as chromatographic peaks or trace impurities of unsubstituted amides, hence they are named "impurities".
Therefore, the natural abundance of N - (3-methoxybenzyl) oleamide in maca is extremely low, and its exact source and biosynthetic mechanism still need further research. It is more likely to be a chemical diversity product that exists in trace amounts within plant bodies or is formed during extraction and processing.
Extraction and Separation Methods
Given its low content and similar structure to the main macaramide, extracting and purifying N - (3-methoxybenzyl) oleamide is a challenging task. The commonly used method is consistent with the general extraction method of macamide, but requires more sophisticated chromatographic techniques for separation.
-
Extract：
- Solvent selection Usually, organic solvents with moderate polarity, such as methanol, ethanol, or their aqueous solutions (such as 70% ethanol), are used for cold soaking or hot reflux extraction. Low polarity solvents such as ethyl acetate and chloroform can also be used to enrich lipophilic components.
- Extraction steps After soaking the dried macagan powder in a solvent, filter and concentrate to obtain the total extract. The total extract can be further subjected to liquid-liquid extraction using solvents of different polarities (such as petroleum ether, ethyl acetate, n-butanol, water) to preliminarily separate components of different polarities. N - (3-methoxybenzyl) oleamide is mainly enriched in petroleum ether or ethyl acetate extraction layers due to its high lipid solubility.
-
Separation and Purification：
- Column chromatography Silica gel column chromatography is the most commonly used preliminary separation method. By using gradient elution systems such as petroleum ether ethyl acetate or chloroform methanol, macaramide compounds can be separated according to their polarity. Methoxy substituted amides may be eluted in later fractions due to their slightly higher polarity than unsubstituted amides.
- High performance liquid chromatography (HPLC)Preparation HPLC is the key to achieving high-purity separation. Usually, a reverse phase C18 chromatography column is used, with acetonitrile water or methanol water as the mobile phase, and eluted by isocratic or gradient elution. Due to the only one methoxy group difference in structure between N - (3-Methoxybenzyl) oleamide and N-benzyl-9Z-octadecanoamide (classical macamide), their retention times are very close, and chromatographic conditions need to be optimized (such as using more efficient chromatographic columns, adjusting mobile phase pH or temperature) to achieve baseline separation.
- Testing and Identification During the separation process, ultraviolet detectors (UV, with amide bond absorption at 210-230 nm) or evaporative light scattering detectors (ELSD) are commonly used for monitoring. The final purified compound needs to be structurally confirmed by spectroscopic techniques such as NMR and MS.
Pharmacological activity research
At present, there are few reports on the specialized pharmacological activity of N - (3-methoxybenzyl) oleamide, and most of the information comes from the study of the overall activity of macamide compounds and inferences based on structural similarity. However, its unique structural features (methoxy substitution) suggest that it may have an activity spectrum different from classical macamide.
Neuroprotection and cognitive improvement
One of the most notable activities of macamide is its neuroprotective effect. Research has shown that various macamides, such as N-benzylhexadecanamide, can inhibit acetylcholinesterase (AChE) activity, thereby increasing the level of acetylcholine in synaptic cleft and improving cognitive function. In addition, they can also protect neurons from damage through antioxidant and anti-inflammatory pathways.
For N - (3-methoxybenzyl) oleamide, the introduction of methoxy groups may alter its binding mode with AChE or other neural targets such as monoamine oxidase MAO. Methoxy, as a hydrogen bond acceptor, may enhance or alter its inhibitory activity by forming additional hydrogen bonds with amino acid residues at the enzyme's active site. Preliminary molecular docking studies or structure-activity relationship analysis may predict its potential AChE or MAO-B inhibitory activity, but direct experimental evidence is still lacking.
Anti fatigue and enhanced physical fitness
One of the traditional uses of maca is to resist fatigue, enhance physical strength and endurance. Macamide is believed to exert this effect by regulating energy metabolism, reducing oxidative stress, and improving mitochondrial function. Oleic acid, as a good substrate for mitochondrial beta oxidation, may be more easily taken up and utilized by cells after acylation. N - (3-methoxybenzyl) oleamide may promote the transport and oxidation of fatty acids through a similar mechanism, improve energy production efficiency, and exhibit anti fatigue activity. However, whether the methoxybenzyl moiety affects its transport within cells or its interaction with specific metabolic enzymes remains to be elucidated.
Reproduction and endocrine regulation
Maca is known for its ability to improve sexual function and fertility. Some macacamides have been reported to have hormone like regulatory effects or exert their effects by affecting the hypothalamic pituitary gonadal axis. For example, certain macacamides can increase the quantity and vitality of sperm. There is currently no direct evidence to determine whether N - (3-methoxybenzyl) oleamide has similar activity. Considering its structural similarity to endogenous cannabinoids (such as anandamide, arachidonic acid ethanolamide), which play important roles in the reproductive system (such as affecting sperm motility, egg fertilization, and embryo implantation), N - (3-methoxybenzyl) oleamide, as a long-chain fatty acid amide, may indirectly affect reproductive function by interacting with endogenous cannabinoid receptors (CB1/CB2) or other related receptors (such as TRPV1). The introduction of methoxy groups may alter their affinity or selectivity towards cannabinoid receptors.
Anti inflammatory and antioxidant properties
Macamide generally has antioxidant activity, which can clear free radicals and inhibit lipid peroxidation. In addition, they can also reduce the production of pro-inflammatory cytokines such as TNF - α and IL-6 by inhibiting inflammatory signaling pathways such as NF - κ B. The oleic acid chain of N - (3-methoxybenzyl) oleamide itself has anti-inflammatory properties (for example, oleic acid can activate PPAR - γ and exert anti-inflammatory effects). After amidation, its anti-inflammatory activity may be enhanced or altered. The methoxybenzyl moiety may also synergistically exert anti-inflammatory effects through its antioxidant activity (methoxyphenol structures are common antioxidant skeletons).
Other potential activities
- antitumor Some macacamides have been reported to be cytotoxic to specific cancer cell lines. The activity of N - (3-methoxybenzyl) oleamide is not yet clear, but its structure is similar to some synthetic fatty acid amides with anti-tumor activity.
- analgesia Long chain fatty acid amides, especially compounds related to the endocannabinoid system, often have analgesic effects. N - (3-methoxybenzyl) oleamide may exert analgesic effects by affecting cannabinoid receptors or transient receptor potential channels (TRP channels).
Mechanism of action and molecular targets
Based on its chemical structure (long-chain fatty acid amides) and limited studies of similar compounds, it can be inferred that N - (3-methoxybenzyl) oleamide may exert its effects through the following mechanisms and targets:
The endocannabinoid system (ECS)
This is the most noteworthy potential target of action. The structure of N - (3-Methoxybenzyl) oleamide is highly similar to the endogenous cannabinoids anandamide and oleamide. They all belong to the fatty acid amide family.
- Cannabinoid receptor (CB1/CB2)It may act as an agonist, antagonist, or partial agonist of CB1 and/or CB2 receptors. Compared to anandamide, its long-chain is oleic acid rather than arachidonic acid, which typically reduces affinity for CB1 receptors but may be selective for CB2 receptors or other non CB1/CB2 targets. The introduction of methoxy groups may further regulate their binding to receptors.
- Fatty acid amide hydrolase (FAAH)FAAH is the main enzyme that degrades anandamide and oleamide. N - (3-methoxybenzyl) oleamide may serve as a substrate or inhibitor of FAAH. As a substrate, it will be hydrolyzed by FAAH into oleic acid and 3-methoxybenzylamine; As an inhibitor, it may indirectly activate ECS by competitively binding and increasing the levels of endogenous anandamide and oleamide. The methoxybenzyl moiety may be more difficult for FAAH to recognize and cleave than a simple benzyl moiety, making it more metabolically stable.
Peroxisome proliferator activated receptors (PPARs)
Long chain fatty acids and their amides are natural ligands for PPARs, especially PPAR - α and PPAR - γ. Oleic acid itself is a weak agonist of PPAR - α. N - (3-methoxybenzyl) oleamide may regulate lipid metabolism, reduce inflammation (by inhibiting NF - κ B), and improve insulin sensitivity by activating PPAR - α. Activation of PPAR - γ may promote adipocyte differentiation and glucose uptake.
Transient receptor potential channels (TRP channels)
Many fatty acid amides are regulators of TRP channels (such as TRPV1, TRPM8). For example, anandamide is an agonist of TRPV1 (capsaicin receptor). N - (3-methoxybenzyl) oleamide may mediate analgesic, anti-inflammatory, or thermoregulatory effects by interacting with TRPV1. The introduction of methoxy groups may affect their binding to TRP channels.
Acetylcholinesterase (AChE) and monoamine oxidase (MAO)
As mentioned earlier, classical macacamide is an inhibitor of AChE and MAO. N - (3-methoxybenzyl) oleamide may bind to the active sites of these enzymes through its amide bond and aromatic ring. The introduction of methoxy groups may lead to different interactions with the catalytic triad (Ser His Glu) or peripheral anionic site (PAS) of AChE, thereby altering its inhibitory activity and selectivity.
Other potential targets
- GPR55 An orphan receptor associated with the cannabinoid system that can be activated by certain fatty acid amides.
- GPR119 A receptor expressed in the pancreas and intestine, which can be activated by oleic ethanolamide (OEA) to regulate insulin secretion and appetite.
- Mitochondrial uncoupling proteins (UCPs)Fatty acids can activate UCPs, promote heat production and energy expenditure. Amidation may affect its transport to mitochondria.
Evaluation of drug properties and pharmacokinetics
At present, there is almost no pharmacological data and pharmacokinetic (PK) studies on N - (3-methoxybenzyl) oleamide. The following analysis is mainly based on its chemical structure and known properties of similar compounds for reasonable prediction.
Drugability assessment
-
Lipinski's Rule of Five：
- Molecular weight: 401.6 Da (<500, compliant)
- Hydrogen bond donor: 1 (amide N-H) (<5, compliant)
- Hydrogen bond acceptor: 3 (amide C=O, ether O) (<10, compliant)
- LogP: The predicted value is between 6-8 (>5, violating the rule). High LogP means that its lipid solubility is too strong, which may lead to poor water solubility, high plasma protein binding rate, high tissue accumulation, and difficult metabolic clearance, making it a typical drug defect.
- Therefore, this compound strictly violates the LogP standard in Lipinski's rules, indicating that its oral bioavailability may be poor and its drug efficacy is facing challenges.
-
Water solubility Poor water solubility is its main problem. This can lead to difficulties in dissolution and absorption after oral administration, requiring the use of special formulation techniques such as liposomes, nanoemulsions, cyclodextrin inclusion complexes, etc. to improve.
-
Metabolic stability：
- Amide bond hydrolysis The amide bond may be hydrolyzed by amidases (such as FAAH) in the body, producing oleic acid and 3-methoxybenzylamine. This is its main metabolic pathway. Metabolites, especially 3-methoxybenzylamine, may have their own pharmacological or toxicological activities.
- oxidative metabolism The double bond and benzyl ring of oleic acid chain are potential sites of action for cytochrome P450 enzyme (CYP450), which may undergo oxidative metabolism such as epoxidation and hydroxylation.
- O-demethylation Methoxy may be demethylated by CYP450 enzymes to produce phenolic hydroxyl metabolites, which can further undergo glucuronidation or sulfation binding reactions.
Pharmacokinetic prediction
- absorb Oral absorption may be poor and unstable, greatly influenced by food and preparations. High LogP makes it easy to enter intestinal epithelial cells through passive diffusion, but poor water solubility limits the dissolution rate. May have a higher tendency for lymphatic absorption.
- distribution Due to its high lipid solubility, the plasma protein binding rate (especially albumin and lipoprotein) is expected to be very high (>99%). The apparent volume of distribution (Vd) will be large, indicating its widespread distribution in tissues, especially adipose tissue, brain, and liver. May be able to cross the blood-brain barrier.
- Metabolism Mainly metabolized in the liver and plasma, metabolic pathways include amide hydrolysis and oxidation. The first pass effect may be significant.
- excretion Metabolites are mainly excreted through urine and bile. The excretion of prototype drugs is extremely low.
Clinical application prospects and prospects
Although the current research foundation of N - (3-methoxybenzyl) oleamide is weak, its unique chemical structure and potential pharmacological activity provide multiple possibilities for its future application prospects.
Potential application areas
- Neurological disorders If its neuroprotective, AChE inhibitory, or MAO inhibitory activity is confirmed, it may become a lead compound for treating neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Its potential analgesic and anti anxiety effects are also worth exploring.
- Metabolic diseases: PPAR - α may play a role in the treatment of metabolic syndrome such as obesity, nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes by activating PPAR - α or regulating ECS.
- Inflammatory diseases Its anti-inflammatory activity makes it potentially useful for treating chronic inflammatory diseases such as arthritis and inflammatory bowel disease.
- Functional foods and dietary supplements As a trace component in maca, it can be developed as a novel functional food additive for improving cognition, anti fatigue, or regulating emotions. But its safety and effectiveness issues need to be addressed first.
Future research directions
- Confirming natural sources and biosynthesis Further plant chemistry research is needed to clarify the exact content, distribution, and biosynthetic pathway of N - (3-methoxybenzyl) oleamide in maca. Can its yield be increased through biotechnology such as cell culture and enzyme engineering?
- Systematic pharmacological activity screening High throughput screening should be performed on the predicted targets (CB1/CB2, FAAH, PPARs, AChE, MAO, TRPV1, etc.) to clarify their activity profiles and selectivity. Meanwhile, its core activities such as neuroprotection, anti-inflammatory, and anti fatigue were validated in cell and animal models.
- In depth study of structure-activity relationships Synthesize a series of structurally similar compounds (changing the chain length, saturation, and double bond position of fatty acids; changing the position and type of substituents on the benzyl ring), systematically study the effect of structural modifications on activity, and search for derivatives with better activity and drug properties.
- Pharmacokinetic and Toxicological Evaluation Conduct preliminary ADME (absorption, distribution, metabolism, excretion) and toxicology studies to evaluate its in vivo behavior, metabolic stability, potential toxicity (especially the safety of its metabolite 3-methoxybenzylamine).
- Formulation development Develop suitable drug delivery systems (such as lipid nanoparticles and self microemulsifying drug delivery system SMEDS) to address the issue of poor water solubility and improve their oral bioavailability.
Conclusion
Impurity 9 (N - (3-Methoxybenzyl) oleamide), as a structurally unique and poorly studied member of the macaramide family, its identity as an "impurity" conceals its potential chemical and biological value. Through in-depth analysis of its chemical structure, physicochemical properties, plant origin, potential pharmacological activity, and mechanism of action, we can clearly see that this molecule is not a simple byproduct, but a natural product analogue carrying rich structural information and potential biological functions.
The methoxy substitution in its structure is an important chemical modification of the classical macaramide skeleton, which may endow it with unique target selectivity and metabolic behavior. Although there is currently a lack of research data, based on the speculation of key targets such as the endocannabinoid system and PPARs, as well as the overall activity spectrum of the macamide family, we have reason to believe that N - (3-methoxybenzyl) oleamide may have pharmacological potential in neuroprotection, anti-inflammatory, metabolic regulation, and other aspects.
However, the road from "potential" to "medicine" is still long and full of challenges. Its poor lipid solubility (high LogP) is the main obstacle to its drug development, while the lack of systematic pharmacokinetic and toxicological data is the biggest risk for its development. Future research needs to start with basic plant chemistry and pharmacological screening, gradually accumulate evidence, and use modern medicinal chemistry methods (such as prodrug design, structural optimization) and formulation techniques to overcome its inherent shortcomings.
In summary, N - (3-Methoxybenzyl) oleamide is a compound worthy of being "named". It should not only be regarded as an impurity peak in a chromatogram, but also as an important bridge molecule connecting natural product chemistry, medicinal chemistry, and pharmacology. In depth research on it not only helps us to have a more comprehensive understanding of the active substance basis of this magical plant, maca, but may also provide valuable clues for discovering new lead compounds for the treatment of neurological, metabolic, and inflammatory diseases. In the field of natural product drug discovery, every overlooked "impurity" may hold the seeds of the next breakthrough.
